Cargando…

Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients

BACKGROUND: Early biomarkers of progression to severe dengue are urgently required to enable effective patient management and control treatment costs. Innate immune cells, which comprise the earliest responders to infection and along with the cytokines and chemokines they secrete, play a vital role...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradeep, Sai Pallavi, Hoovina Venkatesh, Pooja, Manchala, Nageswar R., Vayal Veedu, Arjun, Basavaraju, Rajani K., Selvasundari, Leela, Ramakrishna, Manikanta, Chandrakiran, Yogitha, Krishnamurthy, Vishwanath, Holigi, Shivaranjani, Thomas, Tinku, Ross, Cecil R., Dias, Mary, Satchidanandam, Vijaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318829/
https://www.ncbi.nlm.nih.gov/pubmed/34335578
http://dx.doi.org/10.3389/fimmu.2021.677874
_version_ 1783730326984458240
author Pradeep, Sai Pallavi
Hoovina Venkatesh, Pooja
Manchala, Nageswar R.
Vayal Veedu, Arjun
Basavaraju, Rajani K.
Selvasundari, Leela
Ramakrishna, Manikanta
Chandrakiran, Yogitha
Krishnamurthy, Vishwanath
Holigi, Shivaranjani
Thomas, Tinku
Ross, Cecil R.
Dias, Mary
Satchidanandam, Vijaya
author_facet Pradeep, Sai Pallavi
Hoovina Venkatesh, Pooja
Manchala, Nageswar R.
Vayal Veedu, Arjun
Basavaraju, Rajani K.
Selvasundari, Leela
Ramakrishna, Manikanta
Chandrakiran, Yogitha
Krishnamurthy, Vishwanath
Holigi, Shivaranjani
Thomas, Tinku
Ross, Cecil R.
Dias, Mary
Satchidanandam, Vijaya
author_sort Pradeep, Sai Pallavi
collection PubMed
description BACKGROUND: Early biomarkers of progression to severe dengue are urgently required to enable effective patient management and control treatment costs. Innate immune cells, which comprise the earliest responders to infection and along with the cytokines and chemokines they secrete, play a vital role in orchestrating the subsequent adaptive immune response and have been implicated in the enhancement of infection and “cytokine storm” associated with dengue severity. We investigated the early innate immune cytokine profile of dengue patients during acute phase of disease in a prospective blinded study that included subjects with acute dengue and febrile controls from four major hospitals in Bengaluru, India along with healthy controls. We used intracellular cytokine staining and flow cytometry to identify innate immune biomarkers that can predict progression to severe dengue. RESULTS: Dengue infection resulted in enhanced secretion of multiple cytokines by all queried innate immune cell subsets, dominated by TNF-α from CD56(+)CD3(+) NKT cells, monocyte subsets, and granulocytes along with IFN-γ from CD56(+)CD3(+) NKT cells. Of note, significantly higher proportions of TNF-α secreting granulocytes and monocyte subsets at admission were associated with mild dengue and minimal symptoms. Dengue NS1 antigenemia used as a surrogate of viral load directly correlated with proportion of cytokine-secreting innate immune cells and was significantly higher in those who went on to recover with minimal symptoms. In patients with secondary dengue or those with bleeding or elevated liver enzymes who revealed predisposition to severe outcomes, early activation as well as efficient downregulation of innate responses were compromised. CONCLUSION: Our findings suggested that faulty/delayed kinetics of innate immune activation and downregulation was a driver of disease severity. We identified IFN-γ (+)CD56(+)CD3(+) NKT cells and IL-6(+) granulocytes at admission as novel early biomarkers that can predict the risk of progression to severity (composite AUC = 0.85–0.9). Strong correlations among multiple cytokine-secreting innate cell subsets revealed that coordinated early activation of the entire innate immune system in response to dengue virus infection contributed to resolution of infection and speedy recovery.
format Online
Article
Text
id pubmed-8318829
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83188292021-07-30 Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients Pradeep, Sai Pallavi Hoovina Venkatesh, Pooja Manchala, Nageswar R. Vayal Veedu, Arjun Basavaraju, Rajani K. Selvasundari, Leela Ramakrishna, Manikanta Chandrakiran, Yogitha Krishnamurthy, Vishwanath Holigi, Shivaranjani Thomas, Tinku Ross, Cecil R. Dias, Mary Satchidanandam, Vijaya Front Immunol Immunology BACKGROUND: Early biomarkers of progression to severe dengue are urgently required to enable effective patient management and control treatment costs. Innate immune cells, which comprise the earliest responders to infection and along with the cytokines and chemokines they secrete, play a vital role in orchestrating the subsequent adaptive immune response and have been implicated in the enhancement of infection and “cytokine storm” associated with dengue severity. We investigated the early innate immune cytokine profile of dengue patients during acute phase of disease in a prospective blinded study that included subjects with acute dengue and febrile controls from four major hospitals in Bengaluru, India along with healthy controls. We used intracellular cytokine staining and flow cytometry to identify innate immune biomarkers that can predict progression to severe dengue. RESULTS: Dengue infection resulted in enhanced secretion of multiple cytokines by all queried innate immune cell subsets, dominated by TNF-α from CD56(+)CD3(+) NKT cells, monocyte subsets, and granulocytes along with IFN-γ from CD56(+)CD3(+) NKT cells. Of note, significantly higher proportions of TNF-α secreting granulocytes and monocyte subsets at admission were associated with mild dengue and minimal symptoms. Dengue NS1 antigenemia used as a surrogate of viral load directly correlated with proportion of cytokine-secreting innate immune cells and was significantly higher in those who went on to recover with minimal symptoms. In patients with secondary dengue or those with bleeding or elevated liver enzymes who revealed predisposition to severe outcomes, early activation as well as efficient downregulation of innate responses were compromised. CONCLUSION: Our findings suggested that faulty/delayed kinetics of innate immune activation and downregulation was a driver of disease severity. We identified IFN-γ (+)CD56(+)CD3(+) NKT cells and IL-6(+) granulocytes at admission as novel early biomarkers that can predict the risk of progression to severity (composite AUC = 0.85–0.9). Strong correlations among multiple cytokine-secreting innate cell subsets revealed that coordinated early activation of the entire innate immune system in response to dengue virus infection contributed to resolution of infection and speedy recovery. Frontiers Media S.A. 2021-07-14 /pmc/articles/PMC8318829/ /pubmed/34335578 http://dx.doi.org/10.3389/fimmu.2021.677874 Text en Copyright © 2021 Pradeep, Hoovina Venkatesh, Manchala, Vayal Veedu, Basavaraju, Selvasundari, Ramakrishna, Chandrakiran, Krishnamurthy, Holigi, Thomas, Ross, Dias and Satchidanandam https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Pradeep, Sai Pallavi
Hoovina Venkatesh, Pooja
Manchala, Nageswar R.
Vayal Veedu, Arjun
Basavaraju, Rajani K.
Selvasundari, Leela
Ramakrishna, Manikanta
Chandrakiran, Yogitha
Krishnamurthy, Vishwanath
Holigi, Shivaranjani
Thomas, Tinku
Ross, Cecil R.
Dias, Mary
Satchidanandam, Vijaya
Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients
title Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients
title_full Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients
title_fullStr Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients
title_full_unstemmed Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients
title_short Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients
title_sort innate immune cytokine profiling and biomarker identification for outcome in dengue patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318829/
https://www.ncbi.nlm.nih.gov/pubmed/34335578
http://dx.doi.org/10.3389/fimmu.2021.677874
work_keys_str_mv AT pradeepsaipallavi innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT hoovinavenkateshpooja innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT manchalanageswarr innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT vayalveeduarjun innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT basavarajurajanik innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT selvasundarileela innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT ramakrishnamanikanta innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT chandrakiranyogitha innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT krishnamurthyvishwanath innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT holigishivaranjani innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT thomastinku innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT rosscecilr innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT diasmary innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients
AT satchidanandamvijaya innateimmunecytokineprofilingandbiomarkeridentificationforoutcomeindenguepatients